Literature DB >> 33502824

Chemically-Induced Cross-Linking of Peptidic Fibrils for Scaffolding Polymeric Particles and Macrophages.

Jennifer M Armen1, Nathan R Schueller2,3, Ketki Y Velankar2,3, Nevil Abraham2,3, Rachelle N Palchesko4,5, Yong Fan6,7, Wilson S Meng8,2,3, Ellen S Gawalt1,8.   

Abstract

EAK16-II (EAK) is a self-assembling peptide (SAP) that forms β-sheets and β-fibrils through ionic-complementary interactions at physiological ionic strengths. The soft materials can be injected in vivo, creating depots of drugs and cells for rendering pharmacological and biological actions. The scope of the applications of EAK is sought to extend to tissues through which the flow of extracellular fluid tends to be limited. In such anatomical locales the rate and extent of the fibrilization are limited insofar as drug delivery and cellular scaffolding would be impeded. A method is generated utilizing a carbodiimide cross-linker by which EAK fibrils are pre-assembled yet remain injectable soft materials. It is hypothesized that the resulting de novo covalent linkages enhance the stacking of the β-sheet bilayers, thereby increasing the lengths of the fibrils and the extent of their cross-linking, as evidenced in Diffuse Reflectance Infrared Fourier Transform (DRIFT) spectroscopy, scanning electron microscopy, and atomic force microscopy analyses. The cross-linked EAK (clEAK) retains polymeric microspheres with an average diameter of 1 µm. Macrophages admixed with clEAK remain viable and do not produce the inflammatory mediator interleukin-1β. These results indicate that clEAK should be investigated further as a platform for delivering particles and cells in vivo.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  EAK16-II; cell encapsulation; hydrogels; self-assembling peptides

Mesh:

Substances:

Year:  2021        PMID: 33502824      PMCID: PMC9578542          DOI: 10.1002/mabi.202000350

Source DB:  PubMed          Journal:  Macromol Biosci        ISSN: 1616-5187            Impact factor:   5.859


  57 in total

1.  Concentration effect on the aggregation of a self-assembling oligopeptide.

Authors:  S Y Fung; C Keyes; J Duhamel; P Chen
Journal:  Biophys J       Date:  2003-07       Impact factor: 4.033

Review 2.  Biomedical Applications of Self-Assembling Peptides.

Authors:  Mazda Rad-Malekshahi; Ludwijn Lempsink; Maryam Amidi; Wim E Hennink; Enrico Mastrobattista
Journal:  Bioconjug Chem       Date:  2015-12-11       Impact factor: 4.774

3.  Self-assembling peptides: From a discovery in a yeast protein to diverse uses and beyond.

Authors:  Shuguang Zhang
Journal:  Protein Sci       Date:  2020-10-10       Impact factor: 6.725

Review 4.  Discovery and design of self-assembling peptides.

Authors:  Shuguang Zhang
Journal:  Interface Focus       Date:  2017-10-20       Impact factor: 3.906

5.  The effect of different cross-linking conditions of EDC/NHS on type II collagen scaffolds: an in vitro evaluation.

Authors:  Lu-Ming Nong; Dong Zhou; Dong Zheng; Yu-Qing Jiang; Nan-Wei Xu; Gong-Yin Zhao; Hui Wei; Si-Yuan Zhou; Hui Han; Long Han
Journal:  Cell Tissue Bank       Date:  2019-10-03       Impact factor: 1.522

6.  Polymer based microspheres of aceclofenac as sustained release parenterals for prolonged anti-inflammatory effect.

Authors:  Manpreet Kaur; Sumit Sharma; V R Sinha
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2016-11-25       Impact factor: 7.328

7.  Toward reducing biomaterial antigenic potential: a miniaturized Fc-binding domain for local deposition of antibodies.

Authors:  Ngoc B Pham; Wen Liu; Nathan R Schueller; Ellen S Gawalt; Yong Fan; Wilson S Meng
Journal:  Biomater Sci       Date:  2019-02-26       Impact factor: 6.843

Review 8.  Development of encorafenib for BRAF-mutated advanced melanoma.

Authors:  Peter Koelblinger; Olaf Thuerigen; Reinhard Dummer
Journal:  Curr Opin Oncol       Date:  2018-03       Impact factor: 3.645

Review 9.  Entrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of NTRK, ROS1, and ALK fusion-positive solid tumors.

Authors:  Dazhi Liu; Michael Offin; Stephen Harnicar; Bob T Li; Alexander Drilon
Journal:  Ther Clin Risk Manag       Date:  2018-07-20       Impact factor: 2.423

10.  Zuotin, a putative Z-DNA binding protein in Saccharomyces cerevisiae.

Authors:  S Zhang; C Lockshin; A Herbert; E Winter; A Rich
Journal:  EMBO J       Date:  1992-10       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.